Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

JPT Peptide Technologies

JPT Peptide Technologies GmbH is a leading provider of innovative peptide-based services, and catalog products & kits, as well as a research and development partner for projects in Immunotherapy, Immunology, Proteomics and Drug Discovery.
JPT is ISO 9001 certified and takes pride in its excellent customer support.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

JPT Peptide Technologies
Volmerstr. 5, Berlin, 12489, Germany
Contact JPT Peptide Technologies
Website

 Latest Content from PMHub 

Oxford PharmaGenesis welcomes Christopher Rains on board as our first Non-Executive Director

Press Releases | July 10, 2024 | Oxford PharmaGenesis

Oxford PharmaGenesis is proud to announce the appointment of Christopher Rains as our first Non-Executive Director, strengthening the Board with over 30 years of experience in the pharmaceutical industry. A...

Online Investigator Meetings: A Customer Story

Press Releases | July 9, 2024 | Impetus Digital

Discover how Impetus Digital transformed a multicenter Phase III clinical trial with their innovative virtual solutions.

Medscape Education Showcases Unprecedented Achievements at EHA 2024

Press Releases | July 9, 2024 | Medscape Education

Medscape Education is proud to share its monumental success at the EHA 2024 Congress. Our continued commitment to patient-centric medical education was evident throughout the event, with notable achievements and...

Why a LinkedIn short video feed is so exciting for healthcare comms

Press Releases | July 9, 2024 | Wallace Health

LinkedIn has confirmed that it’s currently experimenting with a short video feed, TikTok-style. This has rather split opinion online, with some seeing it as a mix that won’t work, while...

Reaching Women Where They’re At: Setting Up a Safe Space for HIV Prevention Conversations

Press Releases | July 9, 2024 | Medscape Education

“I always enjoyed solving problems and putting puzzles together,” says Harmony Garges, MD, CMO at ViiV Healthcare and a pediatric infectious disease specialist. “So for me, infectious disease was a...

The MM+M Agency 100 report: Oxford PharmaGenesis is recognized as an industry leader for the fourth year running

Press Releases | July 9, 2024 | Oxford PharmaGenesis

For the fourth year running, media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in its Agency 100 report – the annual definitive ‘who’s who’ ranking of the...

Medscape Education Demonstrates Strong Education Outcomes at the American Diabetes Association 2024 Conference

Press Releases | July 5, 2024 | Medscape Education

Medscape Education presented seven scientific posters at this year’s American Diabetes Association (ADA) conference in Orlando, Florida. These posters highlighted the outcomes of Medscape Education’s continuing medical education programs, which...

Mobile Flexibility – Perks of Virtual Medical Education

Videos and Podcasts | July 4, 2024 | Impetus Digital

Unlock the potential of virtual collaboration with mobile flexibility! Discover how the latest technologies enable you to engage in medical education and collaborate from any corner of the globe. Watch...

The Importance of LGBTQ Diversity in Healthcare

Press Releases | July 3, 2024 | Mednet

We take a look at the importance of ensuring diversity in the Pharma industry

Surrogate endpoints in HTA: Reflections on my HTAi panel discussion

Press Releases | July 2, 2024 | Petauri Evidence

Calum Jones (Associate Director – Health Economics, Mtech Access) shares his experience of speaking at the 2024 HTAi Annual Meeting. Calum participated in the panel discussion: ‘Surrogate Endpoints in Health...